LOS ANGELES, CA & VANCOUVER, BC , Aug. 28, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (“BioSig” or the “Company”), which recently merged with Streamex Exchange Corporation (“Streamex”) (NASDAQ: BSGM), a gold tokenization infrastructure company building the foundation for on-chain gold markets, today announced that it will participate in the 5th annual Needham Virtual Crypto 1x1 Conference on September 4th, 2025. BioSig and Streamex CEO, Henry McPhie and CIO, Mitch Williams will host one on one meeti ...

Core Viewpoint - BioSig Technologies, Inc. has successfully closed an underwritten public offering to support its merger with Streamex Exchange Corporation, focusing on gold tokenization infrastructure [1][2][3]. Group 1: Offering Details - The offering included 3,852,149 shares of common stock priced at $3.90 per share, generating gross proceeds of approximately $15,023,381 before expenses [2]. - The net proceeds will be utilized for purchasing gold bullion, general corporate purposes, and working capital [2]. Group 2: Strategic Intent - The CEO of BioSig emphasized the importance of aligning short and long-term capital strategies with high-quality shareholders to enhance shareholder value [3]. - The company aims to establish itself as a leader in the gold bullion-based real-world asset space, leveraging the recent capital raise [3]. Group 3: Company Background - Streamex is focused on building institutional-grade infrastructure for gold tokenization, supported by a gold-denominated treasury [6]. - BioSig Technologies is a medical device company known for its PURE EP™ Platform, which aids electrophysiologists in treating cardiovascular arrhythmias [7][8].

Company Overview - BioSig Technologies, Inc. recently merged with Streamex Exchange Corporation, enhancing its market position in the gold tokenization sector [1][5] - BioSig is a medical device technology company specializing in advanced digital signal processing technology for electrophysiology [6][7] Public Offering Details - The company announced a public offering of 3,852,149 shares of common stock at a price of $3.90 per share, with expected gross proceeds of approximately $15,023,381.10 [1] - The offering is set to close on or around August 15, 2025, subject to customary closing conditions [1] Use of Proceeds - The net proceeds from the offering will be utilized for purchasing gold bullion, working capital, and general corporate purposes [1] Underwriters - Clear Street and Needham & Company are acting as joint book-running managers for the offering [2] Regulatory Compliance - The offering is made under a shelf registration statement declared effective by the SEC on December 17, 2024, with a final prospectus supplement to be filed [3]

Core Viewpoint - BioSig Technologies, Inc. has announced its intention to offer shares of common stock through an underwritten public offering, following its recent merger with Streamex Exchange Corporation [1] Group 1: Offering Details - The offering will include shares of common stock or pre-funded warrants, with the completion subject to market conditions [1] - The net proceeds from the offering are intended for purchasing gold bullion, working capital, and general corporate purposes [1] - Clear Street and Needham & Company are acting as joint book-running managers for the offering [2] Group 2: Regulatory Information - The offering is made pursuant to a shelf registration statement on Form S-3, declared effective by the SEC on December 17, 2024 [3] - A preliminary prospectus supplement will be filed with the SEC, and interested parties are encouraged to read the documents for more information [3] Group 3: Company Background - BioSig Technologies is a medical device technology company specializing in advanced digital signal processing technology for electrophysiology [6] - The PURE EP™ Platform developed by the company allows for real-time acquisition of raw signal data, enhancing procedural success in ablation treatments [7] - Streamex, a wholly owned subsidiary of BioSig, focuses on gold tokenization and building infrastructure for the gold market [5]

Core Insights - BioSig Technologies, Inc. has appointed Sean Roosen as Strategic Advisor to its wholly owned subsidiary, Streamex Exchange Corporation, following its acquisition in May 2025 [1] - Sean Roosen is a prominent figure in the mining industry with over 30 years of experience, having founded and led multiple successful resource ventures [2][3] - Streamex aims to revolutionize commodity markets through real-world asset tokenization, enhancing liquidity and accessibility in the financial sector [6][8] Company Overview - BioSig Technologies, Inc. is a medical device technology company known for its PURE EP™ Platform, which aids electrophysiologists in treating cardiovascular arrhythmias [9] - Streamex focuses on tokenizing real-world assets in the commodities space, developing infrastructure for primary issuance and exchange [6][8] Leadership and Expertise - Sean Roosen has a notable track record, including founding Osisko Development Corp. and leading Osisko Mining Corporation, which developed the Canadian Malartic mine [2][3] - The advisory board of Streamex includes other industry leaders, such as Frank Giustra, who has founded companies with significant market capitalizations [7] Strategic Vision - The company believes in the future of finance being driven by tokenization and decentralized markets, aiming to bridge traditional finance with the digital economy [8] - Roosen expressed enthusiasm about joining Streamex, highlighting the potential of bringing the resource sector into the digital age through tokenized assets [5]